Our commitment to our subscribers is unwavering. Listed below is our ethics policy. This policy outlines the tenants that guide our service to you.
- We are committed to our subscribers, our goal is to help empower our subscribers with the knowledge needed to make the best possible decisions when investing or trading in the biotech and pharmaceutical sectors.
- We will peer-review and cross-reference each of our reports internally, to ensure the best possible recommendations.
- We do not receive compensation from companies to initiate coverage.
- We will disclose our personal holdings to subscribers if those holdings are currently covered as part of our service. These disclosures can be found in each of our reports where pertinent. Our disclosures will also be aggregated and displayed on our disclosures page.
- We do not do work for hire.
- We do not take positions against our own recommendations.
- We will, from time to time, open positions as described in our reports. We will make this known in our reports. In our opinions, this only works to serve our subscribers more, as our subscribers will know that we have placed our own capital in-line with our recommendations.
- We do not provide real-time access to our personal trades, we feel this distracts from the goal of our service, which is to empower our subscribers with the knowledge needed to make the best possible decision for themselves.
- We appreciate comments and feedback from our subscribers, this service is for you, please feel free to use our contact form to tell us what you think. Annual Members can reach our analysts directly using our Direct Email page.